|
⚲
|
| Keyboard |
| Cary Pfeffer | |
|---|---|
| Firm | |
| Address | 1300 Thames Street Suite 20 Baltimore, MD 21231 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Manat Bio Inc | 021-495585 | Executive Officer | 72.1 M of 153.0 M |
||
| FAZE Medicines Inc | 021-384105 | Executive Officer | 30.4 M of 81.0 M |
||
| Jounce Therapeutics Inc | 021-379231 | Director | 35.0 M of 35.0 M |
||
| Rheos Medicines Inc | 021-309382 | Director | 27.5 M | ||
| Jounce Therapeutics Inc | 021-238833 | Director | 56.0 M of 56.0 M |
||
| Eleven Biotherapeutics Inc | 021-229571 | Director | 20.0 M of 20.0 M |
||
| Edimer Pharmaceuticals Inc | 021-200941 | Director | 9.8 M of 18.0 M |
||
| Taris Biomedical Inc | 021-158321 | Director | 18.4 M of 18.7 M |
||
| Eleven Biotherapeutics Inc | 021-138996 | Executive Officer | 8.8 M of 35.0 M |
||
| Third Rock Ventures LLC | |||||
| Third Rock Ventures VI LP | 021-448880 | Executive Officer | 1,105.3 M of 1,105.3 M |
786.6 M | |
| Third Rock Ventures V LP | 021-341395 | Executive Officer | 750.0 M of 750.0 M |
736.1 M | |
| Third Rock Ventures IV LP | 021-273650 | Executive Officer | 600.0 M of 600.0 M |
326.5 M | |